Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22132057 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CA1CA2CA4 | |
| SCHEMBL3550222 | 0.93 | — | — | |
| SCHEMBL25394100 | 0.93 | — | — | |
| SCHEMBL25733006 | 0.93 | — | — | |
| SCHEMBL24172904 | 0.90 | ALDH1A1 (0.53) | ALDH1A1CA1CA2CA4 | |
| SCHEMBL18404243 | 0.85 | — | — | |
| SCHEMBL17800105 | 0.84 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL5779865 | 0.84 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL2252062 | 0.84 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL9441857 | 0.84 | ALDH1A1 (0.47) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9862657-B2 | Methods for selectively hydrogenating substituted arenes with supported organometallic catalysts | UOP LLC (US) | 2018-01-09 | — | — | US | disclosed |
| US-20160159709-A1 | METHODS FOR SELECTIVELY HYDROGENATING SUBSTITUTED ARENES WITH SUPPORTED ORGANOMETALLIC CATALYSTS | NORTHWESTERN UNIVERSITY | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160159709-A1 | METHODS FOR SELECTIVELY HYDROGENATING SUBSTITUTED ARENES WITH SUPPORTED ORGANOMETALLIC CATALYSTS | HPSE, TST, STS | ALDH1A1 2652/4885CA1 124/4885CA2 229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.